Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Dapagliflozin tablets 10 mg versus Forxiga tablets 10 mg in healthy Thai participants under fasting conditions
TCTR20260416005Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dapagliflozin (2 arms), sponsored by Bio-innova. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
dapagliflozin
Beyond the preview
Go deeper on TCTR20260416005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260416005.